{"id":{"repo_id":"cornell","oai_identifier":"oai:ecommons.cornell.edu:1813/116341"},"canonical_url":"https://search.ndltd.org/etd/cornell/oai:ecommons.cornell.edu:1813/116341","repository":{"repo_id":"cornell","name":"Cornell University","base_url":"https://ecommons.cornell.edu/server/oai/request"},"display":{"title":"Discovery of Carbohydrate-Specific Antibodies from Non-Immune Libraries","abstract":"An antibody library is a diverse repertoire of antibody genes obtained from a donor's immunecells. These genes can be transformed into microorganisms and screened against specific antigens to uncover antibody sequences with affinity towards the target in question. Glycans, which can act as antigens, are cell-surface carbohydrates that contain glycosidic bonds and are used as biomarkers in research and diagnostic settings. Certain glycan expression is upregulated in cancerous cells and therefore is a valuable target for monoclonal antibody immunotherapeutics. However, one challenge to developing monoclonal antibody therapeutics is the time intensive and expensive immunization process. Foregoing this process would involve the usage of naïve libraries, which contain genes from non-immunized donors, and exploits the fact that a naïve library will contain a clone with a certain, albeit low, level of affinity for any given target. Naïve libraries were created from humanized mouse bone marrow and murine splenic cells. Yeast surface display techniques were used to screen these libraries against GD3 and polysialic acid (otherwise known as NeuNAcα2,8). Ultimately, desirable isolated antibody sequences from this process will be able to undergo further processing to become full-length monoclonal antibodies. The usage of this method could render naive antibody libraries as an efficient and valuable tool for antibody discovery, generating new sequences for the treatment of various diseases with upregulated expression of cell-surface GD3 and glycan structures containing polysialic acid.","abstract_html":"An antibody library is a diverse repertoire of antibody genes obtained from a donor&#x27;s immunecells. These genes can be transformed into microorganisms and screened against specific antigens to uncover antibody sequences with affinity towards the target in question. Glycans, which can act as antigens, are cell-surface carbohydrates that contain glycosidic bonds and are used as biomarkers in research and diagnostic settings. Certain glycan expression is upregulated in cancerous cells and therefore is a valuable target for monoclonal antibody immunotherapeutics. However, one challenge to developing monoclonal antibody therapeutics is the time intensive and expensive immunization process. Foregoing this process would involve the usage of naïve libraries, which contain genes from non-immunized donors, and exploits the fact that a naïve library will contain a clone with a certain, albeit low, level of affinity for any given target. Naïve libraries were created from humanized mouse bone marrow and murine splenic cells. Yeast surface display techniques were used to screen these libraries against GD3 and polysialic acid (otherwise known as NeuNAcα2,8). Ultimately, desirable isolated antibody sequences from this process will be able to undergo further processing to become full-length monoclonal antibodies. The usage of this method could render naive antibody libraries as an efficient and valuable tool for antibody discovery, generating new sequences for the treatment of various diseases with upregulated expression of cell-surface GD3 and glycan structures containing polysialic acid.","abstract_has_math":false,"creators":["Walker, Helene"],"institution":"Cornell University","degree_name":"M.S., Chemical Engineering","degree_level":"Master of Science","degree_discipline":"Chemical Engineering","degree_department":null,"school":null,"contributors":[],"advisors":[],"committee_chairs":["DeLisa, Matthew"],"committee_members":["Jiang, Shaoyi","Alabi, Christopher"],"year":2024,"date_issued":"2024-08","date_published":"2024-08","updated_at":"2026-11-19T03:11:32Z","subjects":["antibody","bimolecular engineering","FACS","protein engineering","scFv","yeast surface display"],"languages":["en"],"rights":["Attribution 4.0 International"],"rights_urls":["https://creativecommons.org/licenses/by/4.0/"],"identifier_entries":[{"key":"dc:identifier.doi","label":"DOI","values":["https://doi.org/10.7298/tp3d-8e14"],"render_values":[{"text":"https://doi.org/10.7298/tp3d-8e14","href":"https://doi.org/10.7298/tp3d-8e14","code":true}]},{"key":"dc:identifier.bibid","label":"Dc Identifier Bibid","values":["16611741"],"render_values":[{"text":"16611741","href":null,"code":true}]},{"key":"dc:identifier.other","label":"Dc Identifier Other","values":["ProQuest Submission ID: 12164","ProQuest Publication ID: 31482090"],"render_values":[{"text":"ProQuest Submission ID: 12164","href":null,"code":true},{"text":"ProQuest Publication ID: 31482090","href":null,"code":true}]}],"person_identifier_entries":[]},"links":{"outbound_url":"https://hdl.handle.net/1813/116341","outbound_label":"Handle","outbound_source":"dc:identifier.uri","record_url":"https://hdl.handle.net/1813/116341","record_label":"Repository record","record_kind":"handle","record_source":"dc:identifier.uri","download_url":null,"download_label":null,"download_source":null,"access_status":"embargoed","embargo_until":"2026-09-03","access_note":null},"source_record":{"url":"https://ecommons.cornell.edu/server/oai/request?verb=GetRecord&metadataPrefix=dim&identifier=oai%3Aecommons.cornell.edu%3A1813%2F116341","prefix":"dim"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor.chair","label":"Chair","values":["DeLisa, Matthew"]},{"key":"dc:contributor.committeemember","label":"Committee Member","values":["Jiang, Shaoyi","Alabi, Christopher"]},{"key":"dc:creator","label":"Author","values":["Walker, Helene"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date.accessioned","label":"Dc Date Accessioned","values":["2025-01-14T19:39:58Z"]},{"key":"dc:date.embargo","label":"Dc Date Embargo","values":["2026-09-03"]},{"key":"dc:date.issued","label":"Date","values":["2024-08"]},{"key":"dc:relation.uri","label":"Dc Relation URI","values":["https://newcatalog.library.cornell.edu/catalog/16611741"]},{"key":"dc:type","label":"Dc Type","values":["dissertation or thesis"]},{"key":"thesis:degree_discipline","label":"Discipline","values":["Chemical Engineering"]},{"key":"thesis:degree_level","label":"Degree Level","values":["Master of Science"]},{"key":"thesis:degree_name","label":"Degree Name","values":["M.S., Chemical Engineering"]},{"key":"thesis:institution_name","label":"Thesis Institution Name","values":["Cornell University"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["antibody","bimolecular engineering","FACS","protein engineering","scFv","yeast surface display"]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:language.iso","label":"Language (ISO)","values":["en"]},{"key":"dc:rights","label":"Dc Rights","values":["Attribution 4.0 International"]},{"key":"dc:rights.uri","label":"Rights URI","values":["https://creativecommons.org/licenses/by/4.0/"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier.bibid","label":"Dc Identifier Bibid","values":["16611741"]},{"key":"dc:identifier.doi","label":"DOI","values":["https://doi.org/10.7298/tp3d-8e14"]},{"key":"dc:identifier.other","label":"Dc Identifier Other","values":["ProQuest Submission ID: 12164","ProQuest Publication ID: 31482090"]},{"key":"dc:identifier.uri","label":"Identifier URI","values":["https://hdl.handle.net/1813/116341"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"cerif:openaire","label":"Cerif Openaire","values":["<Publication xmlns=\"https://www.openaire.eu/cerif-profile/1.1/\" id=\"35cf889f-de7e-4adc-be8e-a9a1ae7c08f2\"> <Type xmlns=\"https://www.openaire.eu/cerif-profile/vocab/COAR_Publication_Types\">http://purl.org/coar/resource_type/c_1843</Type> <Language>en</Language> <Title>Discovery of Carbohydrate-Specific Antibodies from Non-Immune Libraries</Title> <PublishedIn> <Publication> </Publication> </PublishedIn> <PublicationDate>2024-08</PublicationDate> <DOI>https://doi.org/10.7298/tp3d-8e14</DOI> <Authors> <Author> <DisplayName>Walker, Helene</DisplayName> <Affiliation> <OrgUnit> </OrgUnit> </Affiliation> </Author> </Authors> <Editors> </Editors> <Publishers> <Publisher> <OrgUnit /> </Publisher> </Publishers> <License>https://creativecommons.org/licenses/by/4.0/</License> <Keyword>antibody</Keyword> <Keyword>bimolecular engineering</Keyword> <Keyword>FACS</Keyword> <Keyword>protein engineering</Keyword> <Keyword>scFv</Keyword> <Keyword>yeast surface display</Keyword> <Abstract>An antibody library is a diverse repertoire of antibody genes obtained from a donor's immunecells. These genes can be transformed into microorganisms and screened against specific antigens to uncover antibody sequences with affinity towards the target in question. Glycans, which can act as antigens, are cell-surface carbohydrates that contain glycosidic bonds and are used as biomarkers in research and diagnostic settings. Certain glycan expression is upregulated in cancerous cells and therefore is a valuable target for monoclonal antibody immunotherapeutics. However, one challenge to developing monoclonal antibody therapeutics is the time intensive and expensive immunization process. Foregoing this process would involve the usage of naïve libraries, which contain genes from non-immunized donors, and exploits the fact that a naïve library will contain a clone with a certain, albeit low, level of affinity for any given target. Naïve libraries were created from humanized mouse bone marrow and murine splenic cells. Yeast surface display techniques were used to screen these libraries against GD3 and polysialic acid (otherwise known as NeuNAcα2,8). Ultimately, desirable isolated antibody sequences from this process will be able to undergo further processing to become full-length monoclonal antibodies. The usage of this method could render naive antibody libraries as an efficient and valuable tool for antibody discovery, generating new sequences for the treatment of various diseases with upregulated expression of cell-surface GD3 and glycan structures containing polysialic acid.</Abstract> <Access xmlns=\"http://purl.org/coar/access_right\" > </Access> </Publication>"]},{"key":"cris:virtual.author","label":"Cris Virtual Author","values":["Walker, Helene"]},{"key":"cris:virtualsource.collection","label":"Cris Virtualsource Collection","values":["5893a6ea-7af3-41d7-abc6-04bcd26ab5df"]},{"key":"dc:description","label":"Description","values":["50 pages"]},{"key":"dc:description.abstract","label":"Abstract","values":["An antibody library is a diverse repertoire of antibody genes obtained from a donor's immunecells. These genes can be transformed into microorganisms and screened against specific antigens to uncover antibody sequences with affinity towards the target in question. Glycans, which can act as antigens, are cell-surface carbohydrates that contain glycosidic bonds and are used as biomarkers in research and diagnostic settings. Certain glycan expression is upregulated in cancerous cells and therefore is a valuable target for monoclonal antibody immunotherapeutics. However, one challenge to developing monoclonal antibody therapeutics is the time intensive and expensive immunization process. Foregoing this process would involve the usage of naïve libraries, which contain genes from non-immunized donors, and exploits the fact that a naïve library will contain a clone with a certain, albeit low, level of affinity for any given target. Naïve libraries were created from humanized mouse bone marrow and murine splenic cells. Yeast surface display techniques were used to screen these libraries against GD3 and polysialic acid (otherwise known as NeuNAcα2,8). Ultimately, desirable isolated antibody sequences from this process will be able to undergo further processing to become full-length monoclonal antibodies. The usage of this method could render naive antibody libraries as an efficient and valuable tool for antibody discovery, generating new sequences for the treatment of various diseases with upregulated expression of cell-surface GD3 and glycan structures containing polysialic acid."]},{"key":"dc:description.collection","label":"Dc Description Collection","values":["Cornell Theses and Dissertations"]},{"key":"dc:format.mimetype","label":"Dc Format Mimetype","values":["application/pdf"]},{"key":"dcterms:license","label":"Dcterms License","values":["https://hdl.handle.net/1813/59810.2"]},{"key":"dc:title","label":"Title","values":["Discovery of Carbohydrate-Specific Antibodies from Non-Immune Libraries"]},{"key":"dspace:entity.type","label":"Dspace Entity Type","values":["Publication"]},{"key":"others:access_status","label":"Others Access Status","values":["embargo"]}]}],"canonical_facts":{"cerif:openaire":["<Publication xmlns=\"https://www.openaire.eu/cerif-profile/1.1/\" id=\"35cf889f-de7e-4adc-be8e-a9a1ae7c08f2\"> <Type xmlns=\"https://www.openaire.eu/cerif-profile/vocab/COAR_Publication_Types\">http://purl.org/coar/resource_type/c_1843</Type> <Language>en</Language> <Title>Discovery of Carbohydrate-Specific Antibodies from Non-Immune Libraries</Title> <PublishedIn> <Publication> </Publication> </PublishedIn> <PublicationDate>2024-08</PublicationDate> <DOI>https://doi.org/10.7298/tp3d-8e14</DOI> <Authors> <Author> <DisplayName>Walker, Helene</DisplayName> <Affiliation> <OrgUnit> </OrgUnit> </Affiliation> </Author> </Authors> <Editors> </Editors> <Publishers> <Publisher> <OrgUnit /> </Publisher> </Publishers> <License>https://creativecommons.org/licenses/by/4.0/</License> <Keyword>antibody</Keyword> <Keyword>bimolecular engineering</Keyword> <Keyword>FACS</Keyword> <Keyword>protein engineering</Keyword> <Keyword>scFv</Keyword> <Keyword>yeast surface display</Keyword> <Abstract>An antibody library is a diverse repertoire of antibody genes obtained from a donor's immunecells. These genes can be transformed into microorganisms and screened against specific antigens to uncover antibody sequences with affinity towards the target in question. Glycans, which can act as antigens, are cell-surface carbohydrates that contain glycosidic bonds and are used as biomarkers in research and diagnostic settings. Certain glycan expression is upregulated in cancerous cells and therefore is a valuable target for monoclonal antibody immunotherapeutics. However, one challenge to developing monoclonal antibody therapeutics is the time intensive and expensive immunization process. Foregoing this process would involve the usage of naïve libraries, which contain genes from non-immunized donors, and exploits the fact that a naïve library will contain a clone with a certain, albeit low, level of affinity for any given target. Naïve libraries were created from humanized mouse bone marrow and murine splenic cells. Yeast surface display techniques were used to screen these libraries against GD3 and polysialic acid (otherwise known as NeuNAcα2,8). Ultimately, desirable isolated antibody sequences from this process will be able to undergo further processing to become full-length monoclonal antibodies. The usage of this method could render naive antibody libraries as an efficient and valuable tool for antibody discovery, generating new sequences for the treatment of various diseases with upregulated expression of cell-surface GD3 and glycan structures containing polysialic acid.</Abstract> <Access xmlns=\"http://purl.org/coar/access_right\" > </Access> </Publication>"],"cris:virtual.author":["Walker, Helene"],"cris:virtualsource.collection":["5893a6ea-7af3-41d7-abc6-04bcd26ab5df"],"dc:contributor.chair":["DeLisa, Matthew"],"dc:contributor.committeemember":["Jiang, Shaoyi","Alabi, Christopher"],"dc:creator":["Walker, Helene"],"dc:date.accessioned":["2025-01-14T19:39:58Z"],"dc:date.embargo":["2026-09-03"],"dc:date.issued":["2024-08"],"dc:description":["50 pages"],"dc:description.abstract":["An antibody library is a diverse repertoire of antibody genes obtained from a donor's immunecells. These genes can be transformed into microorganisms and screened against specific antigens to uncover antibody sequences with affinity towards the target in question. Glycans, which can act as antigens, are cell-surface carbohydrates that contain glycosidic bonds and are used as biomarkers in research and diagnostic settings. Certain glycan expression is upregulated in cancerous cells and therefore is a valuable target for monoclonal antibody immunotherapeutics. However, one challenge to developing monoclonal antibody therapeutics is the time intensive and expensive immunization process. Foregoing this process would involve the usage of naïve libraries, which contain genes from non-immunized donors, and exploits the fact that a naïve library will contain a clone with a certain, albeit low, level of affinity for any given target. Naïve libraries were created from humanized mouse bone marrow and murine splenic cells. Yeast surface display techniques were used to screen these libraries against GD3 and polysialic acid (otherwise known as NeuNAcα2,8). Ultimately, desirable isolated antibody sequences from this process will be able to undergo further processing to become full-length monoclonal antibodies. The usage of this method could render naive antibody libraries as an efficient and valuable tool for antibody discovery, generating new sequences for the treatment of various diseases with upregulated expression of cell-surface GD3 and glycan structures containing polysialic acid."],"dc:description.collection":["Cornell Theses and Dissertations"],"dc:format.mimetype":["application/pdf"],"dc:identifier.bibid":["16611741"],"dc:identifier.doi":["https://doi.org/10.7298/tp3d-8e14"],"dc:identifier.other":["ProQuest Submission ID: 12164","ProQuest Publication ID: 31482090"],"dc:identifier.uri":["https://hdl.handle.net/1813/116341"],"dc:language.iso":["en"],"dc:relation.uri":["https://newcatalog.library.cornell.edu/catalog/16611741"],"dc:rights":["Attribution 4.0 International"],"dc:rights.uri":["https://creativecommons.org/licenses/by/4.0/"],"dc:subject":["antibody","bimolecular engineering","FACS","protein engineering","scFv","yeast surface display"],"dcterms:license":["https://hdl.handle.net/1813/59810.2"],"dc:title":["Discovery of Carbohydrate-Specific Antibodies from Non-Immune Libraries"],"dc:type":["dissertation or thesis"],"dspace:entity.type":["Publication"],"others:access_status":["embargo"],"thesis:degree_discipline":["Chemical Engineering"],"thesis:degree_level":["Master of Science"],"thesis:degree_name":["M.S., Chemical Engineering"],"thesis:institution_name":["Cornell University"]},"updated_at":"2026-11-19T03:11:32Z"}